my-mask® is an extremely lightweight, portable and convenient solution. Both the device’s body and the mask terminal have been designed to grant patients with the greatest comfort in administering (or self-administering) our light-based therapy (Light Modulation™ LLLT).
my-mask® enables a full therapy, covering both lower and upper eyelids, to grant maximum efficacy in treating Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD) and other ocular surface conditions.
my-mask® and LM™ LLLT provide patients with an entirely non-invasive therapy. Near-infrared light is emitted on the skin at a medically-certified wavelength, generating endogenous heating by stimulating cells’ ATP production.
For patients, this means immediate relief just after the 15’ therapy—for operators, it means delivering greater value to patients, with much less effort.
